###begin article-title 0
A study of the average effect of the 3'APOB-VNTR polymorphism on lipidemic parameters could explain why the short alleles (<35 repeats) are rare in centenarians
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Short</italic>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Medium</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Long</italic>
###xml 179 180 179 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 215 218 215 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SS </italic>
###xml 361 363 361 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
In studies on the genetics of human aging, we observed an age-related variation of the 3'APOB-VNTR genotypic pool (alleles: Short, S, <35 repeats; Medium, M, 35-39 repeats; Long, L, >39 repeats) with the homozygous SS genotype showing a convex frequency trajectory in a healthy aging population. This genotype was rare in centenarians, thus indicating that the S alleles are unfavorable to longevity, while common in adults, thus indicating a protective role at middle age. This apparent paradox could be due to possible effects exerted by the above polymorphism on lipidemic parameters. Aim of the work was to get insights into these puzzling findings
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 83 84 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 87 89 83 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 95 96 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M</sub>
###xml 103 105 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 111 112 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 259 260 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 269 270 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M</sub>
###xml 283 284 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 462 464 438 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 753 755 729 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 169 175 <span type="species:ncbi:9606">people</span>
###xml 551 559 <span type="species:ncbi:9606">patients</span>
###xml 658 666 <span type="species:ncbi:9606">patients</span>
###xml 780 788 <span type="species:ncbi:9606">patients</span>
We followed a double strategy. Firstly, we analyzed the average effects of S (alphaS), M (alphaM), and L (alphaL) alleles on lipidemic parameters in a sample of healthy people (409 subjects aged 20-102 years) recruited in Calabria (southern Italy). The (alphaS), (alphaM), and (alphaL) values were estimated by relating 3'APOB-VNTR genotypes to lipidemic parameters, after adjustment for age, sex and body mass index (multiple regression). Then, we analyzed the S alleles as susceptibility factors of Cardiovascular Atherosclerotic Disease (CD) in CD patients characterized either by low serum HDL-Cholesterol or by high serum LDL-Cholesterol (CD-H and CD-L patients, 40 and 40 subjects respectively). The Odds Ratios (OR) were computed for carriers of S alleles in CD-H and CD-L patients matched for origin, sex and age with controls extracted from the sample of healthy subjects.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 62 64 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 130 132 126 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 219 221 211 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S </sub>
###xml 299 301 291 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 305 307 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 435 437 427 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 410 418 <span type="species:ncbi:9606">patients</span>
By the analysis of the healthy sample group we found that the S alleles lower the average values of serum Total Cholesterol (alphaS = -5.98 mg/dL with [-11.62 / -0.74] 95% confidence interval) and LDL-Cholesterol (alphaS = -4.41 mg/dL with [-8.93 / -0.20] 95% confidence interval) while the alleles M and L have no significant effect on the lipidemic phenotype. In line with these findings, the analysis of CD patients showed that the S alleles are protective as for CD-L (O.R. = 0.55 with [0.21 / 0.98] 95% confidence interval) while neutral as for CD-H (O.R. = 0.75 with [0.32 / 1.60] 95% confidence interval).
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 18 20 18 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SS </italic>
On the whole, the S alleles would be advantageous in adults (by protecting from CD-L) while dangerous in the elderly, probably by lowering serum cholesterol below a critical threshold. This could explain the convex frequency trajectory of SS genotypes previously observed in a healthy aging population.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 692 693 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
It is well known that the serum level of Low Density Lipoprotein - Cholesterol (LDL-C) is positively correlated with proneness to atherosclerosis and cardiovascular diseases. Apolipoprotein B (ApoB) is the main component of LDL and the variability of the APOB gene may play a role in the genetic susceptibility to such diseases by modulating the average effects exerted by APOB variants on the lipidemic phenotype [1,2]. A VNTR polymorphism, which is located 75 bp downstream the second polyadenylation signal at the 3' end of the APOB gene (2p24-p23) has been suggested as one of the factors which modulate liability to coronary heart disease, at least in populations of Caucasian ancestry [3,4] possibly through allele-specific expressions of the APOB gene [5].
###end p 10
###begin p 11
###xml 223 231 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Small, S</italic>
###xml 246 257 246 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Medium, M, </italic>
###xml 272 282 272 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Large, L, </italic>
###xml 342 345 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SS </italic>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SS </italic>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 868 870 868 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 876 877 872 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 880 882 876 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 888 889 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M</sub>
###xml 896 898 888 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 904 905 892 893 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 1075 1083 <span type="species:ncbi:9606">patients</span>
###xml 1247 1255 <span type="species:ncbi:9606">patients</span>
Recently, in gene/longevity association studies, we analyzed the changes of the gene pool relevant to the 3'APOB-VNTR polymorphism in healthy aging populations. By re-coding the 3'APOB-VNTR alleles into three size classes (Small, S, <35 repeats; Medium, M, 35-39 repeats; Large, L, > 39 repeats) we found that the frequency of the homozygous SS genotype was very low in oldest old subjects [6] and decreased in the population following an age-related convex trajectory [7]. The non linear trajectory suggested that the SS genotype was protective in younger individuals, while frail in the new scenario that comes out when age increases [8]. This puzzling finding could be due, at least in part, to a possible association between the 3'APOB-VNTR polymorphism and lipidemic parameters. Aim of the present study was to check this idea by analyzing the average effects of S (alphaS), M (alphaM), and L (alphaL) alleles on lipidemic parameters in a sample group of healthy subjects. Then, to check the indications given by the study of the allele average effect, we also analyzed patients affected by Cardiovascular Atherosclerotic Disease (CD) who were characterized either by low serum HDL-Cholesterol or by high serum LDL-Cholesterol (CD-H and CD-L patients respectively).
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Healthy group
###end title 13
###begin p 14
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
The sampling was carried out in a well defined geographic area (Calabria, southern Italy) taking care to minimize possible heterogeneity factors as previously described [9]. The samples were recruited by an appropriate campaign focused on University' students and staff (18- to 60-year age range), thermal baths and University for the Elderly (61- to 95-year age range); while the centenarians were identified by consulting the Population Registers of the Municipalities of Calabria, contacted by phone and then visited. Routine blood analyses were carried out in each subject and, in addition, subjects older than 60 years underwent a complete clinical and geriatric assessment. Subjects having blood parameters in the sex- and age-specific normal range, none taking regular medication, and free of clinically overt pathologies were enrolled in the study (169 males and 240 females; 20-102 years age-range). In particular, centenarians were from the categories A and B previously described [10].
###end p 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 15
###begin p 16
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 707 715 <span type="species:ncbi:9606">patients</span>
Eighty male patients affected by Cardiovascular Atherosclerotic Disease (46-80 years age-range) and characterized either by a low level of serum HDL-C (CD-H patients, n = 40) or by a high level of serum LDL-C (CD-L patients, n = 40) were recruited at the Italian National Research Center on Aging (INRCA) in Cosenza (Calabria, southern Italy). About 70% of the patients were settled in the hospital, while the remaining were ambulatory visited. All the patients were matched for ethnicity, origin, residence, age and sex with the appropriate sub-group of healthy subjects. Diagnostic criteria for the inclusion in the study are reported in Table 1, while Table 2 shows lipidemic parameters in CD-H and CD-L patients.
###end p 16
###begin p 17
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Diagnostic criteria used to identify CD-H and CD-L patients with Cardiovascular Atherosclerotic Disease (CD)
###end p 17
###begin p 18
*Cutoff values were chosen on the basis of the average serum levels of HDL-C and LDL-C in southern Italian adult males not affected by any clinically manifest disease.
###end p 18
###begin p 19
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Lipidemic parameters (mg/dL) in the samples of CD patients (46-80 years age range). Mean values with standard deviation in parenthesis.
###end p 19
###begin p 20
CD-H: Cardiovascular Disease with low level of HDL-C; CD-L: Cardiovascular Disease with high level of LDL-C; TC: serum Total Cholesterol; HDL-C: serum HDL-Cholesterol; LDL-C: serum LDL-Cholesterol (TC - HDL-C - TG/5); TG: serum Tryglycerides
###end p 20
###begin p 21
###xml 48 54 <span type="species:ncbi:9606">people</span>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
All the subjects, both in the sample of healthy people and in that of patients, were unrelated and had given their written informed consent to the present study.
###end p 21
###begin title 22
Molecular analyses
###end title 22
###begin p 23
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The 3'APOB-VNTR polymorphism was typed as described [6] on PCR-amplified DNA extracted from blood buffy coats.
###end p 23
###begin p 24
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R </sup>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
As for the lipidemic parameters, serum Total Cholesterol (TC), HDL-Cholesterol (HDL-C), Tryglycerides (TG) were measured in each subject (12 hrs. overnight fast) by enzymatic colorimetric method with commercial kits (Dade Behring) in an automated chemistry analyzer (DimensionR Clinical Chemistry System). LDL-Cholesterol (LDL-C) was estimated by the Friedewald's formula [11].
###end p 24
###begin title 25
Statistical analyses
###end title 25
###begin p 26
###xml 9 10 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 17 18 9 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M</sub>
###xml 25 27 13 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 54 55 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 57 60 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M, </italic>
###xml 64 66 52 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 203 205 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 264 266 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 420 421 406 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 485 486 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 493 494 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M</sub>
###xml 501 503 475 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
The alphaS, alphaM, alphaL average effects exerted by S, M, and L alleles respectively on the lipidemic parameters were estimated in the sample of healthy subjects according to Christiansen and Feldman [12] after verification of the Hardy-Weinberg equilibrium (chi2 test). Lipidemic data were used after removing trends due to age, sex and Body Mass Index (computed according to the formula: BMI = weight [Kg]/ height [m2]) by multiple regression. The 95% confidence intervals of alphaS, alphaM, alphaL were calculated by bootstrap (1,000 replications, MATLAB Statistic toolbox).
###end p 26
###begin p 27
###xml 73 75 73 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
The Odds Ratios (OR) in CD-H and CD-L were estimated for the carriers of S alleles (homozygous plus heterozygous subjects) with respect to sex- and age-matched controls extracted from the sample of healthy subjects. The 95% confidence intervals of OR were computed by bootstrap (1,000 replications, MATLAB Statistic toolbox).
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Estimation of allele-average effects
###end title 29
###begin p 30
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 347 348 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 355 356 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M</sub>
###xml 363 365 351 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 469 470 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 502 504 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
The genotype/phenotype relationship between 3'APOB-VNTR variability and lipidemic parameters was analyzed in the sample of healthy subjects by estimation of allelic average effects on lipidemic parameters. Tables 3 and 4 summarize lipidemic data (stratified according to age and sex) and genetic data respectively. The allele average effects alphaS, alphaM, alphaL on serum TC, HDL-C, LDL-C and TG, after adjustment for age, sex and Body Mass Index, are shown in Table 5, where it can be seen that the S alleles significantly lower the serum level of both TC and LDL-C (95% c.i. non including 0).
###end p 30
###begin p 31
Lipidemic parameters (mg/dL) in the sample of healthy subjects stratified for age. Mean values with standard deviation in parenthesis.
###end p 31
###begin p 32
TC: serum Total Cholesterol; HDL-C: serum HDL-Cholesterol; LDL-C: serum LDL-Cholesterol (TC - HDL.C - TG/5); TG: serum Tryglycerides
###end p 32
###begin p 33
3'APOB-VNTR genotypes, with Hardy-Weinberg equilibrium (HWE) expected values, in the sample of healthy subjects. Absolute and relative allelic frequencies (with standard errors) are also shown.
###end p 33
###begin p 34
###xml 4 6 2 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 45 47 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 61 63 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 78 80 76 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
*chi2 = 3.44 with 3 d.f.; p = 0.328 Alleles: S < 35 repeats; M 35-39 repeats; L > 39 repeats.
###end p 34
###begin p 35
###xml 28 29 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">S</sub>
###xml 36 38 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M </sub>
###xml 47 49 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L </sub>
###xml 63 64 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 66 68 54 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 72 74 60 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 272 273 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Allele average effects alphaS, alphaM and alphaL estimated for S, M and L alleles respectively of the 3'VNTR-APOB polymorphism in the whole sample of healthy subjects after normalization for age, sex and BMI (computed according to the formula: BMI = weight [Kg]/ height [m2])
###end p 35
###begin p 36
TC: serum Total Cholesterol; HDL-C: serum HDL-Cholesterol; LDL-C: serum LDL-Cholesterol; TG: serum Tryglycerides. Average effects are expressed in mg/dL. Confidence intervals (c.i.) are computed by bootstrap (1,000 replications).
###end p 36
###begin title 37
3'APOB-VNTR alleles in CD
###end title 37
###begin p 38
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 274 276 274 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 324 326 324 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
The genotypic and allelic frequencies in CD-H and CD-L patients, with those in sex- and age-matched controls used to compute OR values, are shown in the Table 6. According with the results of the study of allele average effects, that showed a specific effect exerted by the S alleles on both TC and LDL-C, we found that the S alleles are protective in CD-L (OR = 0.55; [0.21 / 0.98] 95% c.i.) while neutral in CD-H (O.R. = 0.75; [0.32 / 1.60] 95% c.i.).
###end p 38
###begin p 39
###xml 276 278 274 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 291 293 289 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M </italic>
###xml 307 309 305 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L </italic>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
3'APOB-VNTR absolute (Abs.) and Relative (Rel.) genotypic and allelic frequencies (+/- Standard Error) in CD-H and CD-L patients and in sex and age matched controls (males; 46-80 year age range). Values expected at Hardy-Weinberg equilibrium (HWE) are in parenthesis. Alleles:S < 35 repeats;M 35-39 repeats;L >39 repeats.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 758 760 758 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 485 491 <span type="species:ncbi:9606">people</span>
The study showed an allele-specific association between the 3'APOB-VNTR variability and lipidemic parameters in a southern Italian population. Although association studies should be carefully considered due to the possibility of false positive findings, we are confident that the results of the present study are reliable for three reasons. Firstly, the lowering effect exerted by the 3 APOB-VNTR short alleles on serum TC and LDL-C had been previously observed in a sample of healthy people from Belgrade [13]. Secondly, the typing of a moderate number of neutral markers spread across the genome [14] did not show stratification in the sample we analyzed (unpublished results). Thirdly, and mostly important, the significant lowering effect exerted by the S alleles on serum LDL-C (Table 5) is in line with the finding that these alleles are protective for CD-L (O.R. = 0.55 with [0.21 / 0.98] 95% confidence interval) while neutral for CD-H.
###end p 41
###begin p 42
###xml 34 36 34 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SS </italic>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SS </italic>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 187 193 <span type="species:ncbi:9606">people</span>
###xml 572 578 <span type="species:ncbi:9606">people</span>
The average effect exerted by the S alleles on TC and LDL-C, and their protective role in CD-L, could explain why the SS homozygous genotype was over-represented in an adult age-class of people selected for healthy status [7]. However, as age increases, both TC and LDL-C serum levels decline as shown by the population data in Table 3. In this new physiological situation, the SS genotypes, that was protective at adult age, may turn out to be detrimental at old age, because the serum levels of TC and LDL-C may drop out below a critical threshold. In fact, in very old people, a high serum TC concentration is associated with increased survival [15,16].
###end p 42
###begin title 43
Conclusions
###end title 43
###begin p 44
###xml 40 42 40 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S </italic>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
###xml 696 703 <span type="species:ncbi:9606">persons</span>
The data here presented showed that the S alleles of the 3'APOB-VNTR polymorphism (less than 35 repeats) are associated with low levels of both TC and LDL-C in a population from southern Italy. This finding can explain why these alleles were over-represented in a sample of healthy adults [7] while rare in a sample of CD-L patients, characterized by high level of serum LDL-C. From this point of view, the S alleles could be regarded as beneficial for healthy ageing. However, the observation that these alleles are rare in centenarians [6,7] indicates that they are detrimental for longevity, probably because of their effect on lipidemic parameters in the physiological background of very old persons. On the whole, the study confirms that genetic risk factors are age-specific and gets possible insights on another "paradox of centenarians" [17].
###end p 44
###begin title 45
Competing interests
###end title 45
###begin p 46
None declared.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
SG: genotyping; MB: sampling and clinical analyses; FDR: data mining; VM: laboratory and clinical analyses; EF clinical diagnosis; GDB: work hypothesis, study design, and coordination. All the authors discussed the data and participated to the draft of the manuscript, that was finalized by GDB.
###end p 48
###begin title 49
Pre-publication history
###end title 49
###begin p 50
The pre-publication history for this paper can be accessed here:
###end p 50
###begin p 51

###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
###xml 64 122 64 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Marcatori biologici di invecchiamento normale e patologico</italic>
Work funded by the Italian Ministry of Health (IRCCS 2000-2002. Marcatori biologici di invecchiamento normale e patologico) and by the Italian National Research Center on Aging (INRCA, Ancona and Cosenza, Italy).
###end p 53
###begin article-title 54
Recent progress in understanding apolipoprotein B
###end article-title 54
###begin article-title 55
The effect of variation in the apolipoprotein B gene on plasmid lipid and apolipoprotein B levels. A likelihood-based approach to cladistic analysis
###end article-title 55
###begin article-title 56
Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction
###end article-title 56
###begin article-title 57
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls
###end article-title 57
###begin article-title 58
###xml 58 63 <span type="species:ncbi:9606">human</span>
Structure and function of alleles in the 3' end region of human apoB gene
###end article-title 58
###begin article-title 59
DNA multiallelic systems reveal gene/longevity associations not detected by diallelic systems. The APOB locus
###end article-title 59
###begin article-title 60
Age-related changes of the 3'APOB-VNTR genotype pool in ageing cohorts
###end article-title 60
###begin article-title 61
The age dependency of gene expression for plasma lipids, lipoproteins, and apolipoproteins
###end article-title 61
###begin article-title 62
###xml 66 72 <span type="species:ncbi:9606">people</span>
The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects
###end article-title 62
###begin article-title 63
###xml 3 6 <span type="species:ncbi:9606">men</span>
###xml 11 16 <span type="species:ncbi:9606">women</span>
Do men and women follow different trajectories to reach extreme longevity ?
###end article-title 63
###begin article-title 64
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
###end article-title 64
###begin article-title 65
APO B 3' HVR polymorphism in healthy population: relationships to serum lipid levels
###end article-title 65
###begin article-title 66
Case-control studies of association in structured or admixed populations
###end article-title 66
###begin article-title 67
###xml 47 53 <span type="species:ncbi:9606">people</span>
Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study
###end article-title 67
###begin article-title 68
Total cholesterol and risk of mortality in the oldest old
###end article-title 68
###begin article-title 69
Are common risk factors relevant in the eldest old ?
###end article-title 69

